Neoadjuvant and adjuvant antitumor vaccination alone or combination with PD1 blockade and CD137 agonism in patients with resectable pancreatic adenocarcinoma Meeting Abstract


Authors: Heumann, T. R.; Judkins, C.; Lim, S. J.; Wang, H.; Parkinson, R.; Gai, J.; Celiker, B.; Durham, J. N.; Laheru, D. A.; De Jesus-Acosta, A.; Le, D. T.; Narang, A.; Anders, R. A.; Soares, K.; Burkhart, R. A.; Burns, W.; Thompson, E.; He, J.; Jaffee, E. M.; Zheng, L.
Abstract Title: Neoadjuvant and adjuvant antitumor vaccination alone or combination with PD1 blockade and CD137 agonism in patients with resectable pancreatic adenocarcinoma
Meeting Title: 2022 ASCO Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 4 Suppl.
Meeting Dates: 2022 Jan 20-22
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-02-01
Language: English
ACCESSION: WOS:000770995900541
DOI: 10.1200/JCO.2022.40.4_suppl.558
PROVIDER: wos
Notes: Meeting Abstract: 558 -- Meeting was conducted online as well as in person -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kevin Cerqueira Soares
    135 Soares